FDA Approval of a New Drug Elrexfio Offers More Option for Multiple Myeloma

Updated January 22nd, 2024

FDA Approval of a New Drug Elrexfio Offers More Option for Multiple Myeloma

close

Patient Pathfinder

We’re here to help. Have you had any treatment for myeloma yet?

You might want to check out some top experts outlining the initial treatment for myeloma.

Got it. Are you looking for maintenance treatment?

You might want to check out some top experts outlining maintenance treatment for myeloma.

Ok. Has your Myeloma come back? Here are some useful resources:

If you’ve had at least four treatments that have not worked or stopped working you might be a candidate for a treatment called CAR T Therapy.

NOW
PLAYING
Patricia Arquette's Quest to Boost Breast Cancer Screening After Losing Mom to Disease
NOW
PLAYING
Targeted Therapy Revolution: For People With Cancers That Have A Special Factor Called HER2, The Drug Enhertu Is Now Approved Across Tumor Types- What To Ask Your Doctor
NOW
PLAYING
Groundbreaking CAR T-Cell Therapy Approved For Earlier Use in Relapsed Myeloma Patients
NOW
PLAYING
New Hope for Ovarian Cancer: FDA Approves Targeted Drug ELAHERE for Certain Patients With Difficult-to-Manage Disease
NOW
PLAYING
What You Need to Know About the New Drug for Myelodysplastic Syndrome
NOW
PLAYING
Major Victory For CAR T-Cell Therapy in Multiple Myeloma: FDA Advisory Panel Support For Abecma and Carvykti Therapies Earlier in The Disease Course, Despite Safety Concerns

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... multiple myeloma trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.